Skip to content
OpenCapital
Get started

CONMED CNMD Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest at other companies

TFX
TeleflexTFX
-$27.63M-123%
Medtronic logo
MedtronicMDT
——
Intuitive Surgical logo
Intuitive SurgicalISRG
——
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest?
CONMED (CNMD) reported comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest of $15.44M in Q1 2026.
How has CONMED's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest changed year-over-year?
CONMED's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest increased by 105.8% year-over-year, from $7.5M to $15.44M.
What is the long-term trend for CONMED's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest?
Over 3 years (2021 to 2025), CONMED's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest has grown at a -6.1% compound annual growth rate (CAGR), from $72.02M to $59.62M.
What does comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest mean?
Combines net income with other comprehensive income to provide a holistic view of the company's total financial performance for the period. It includes all changes in equity, including those attributable to noncontrolling interests, providing a complete picture of value creation.